Mangalasseril G. Sarngadharan
20Patents
7h-index
26Co-inventors
65Inventor score
Filing activity: Apr 23, 1984 → Jul 17, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4520113A | Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions | Emerging Cross-Sectional Technologies | 167 | Expired |
| US4708818A | Human immunodeficiency viruses associated with Acquired Immune Deficiency Syndrome (AIDS), a diagnostic method for AIDS and pre-AIDS, and a kit therefor | Emerging Cross-Sectional Technologies | 145 | Expired |
| US4843011A | Monoclonal antibodies for binding HTLV-III proteins, and cell lines for their production | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5518723A | HIV immunogenic complexes | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5135864A | Human Immunodeficiency Virus (HIV) associated with Acquired Immunual Deficiency Syndrome (AIDS), a diagnostic method for aids and pre-aids, and a kit therefor | Emerging Cross-Sectional Technologies | 20 | Expired |
| US5843454A | HIV immunogenic complexes | Emerging Cross-Sectional Technologies | 19 | Expired |
| US6030772A | Neutralizing antibodies against HIV infection | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6627395B1 | Methods for the propagation, isolation, identification, and preparation of human immunodeficiency virus type 1 (HIV-1) | Physics | 7 | Expired |
| US5116740A | Method for producing native HIV gp160 | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6465172B1 | HIV immunogenic complexes comprising GP120 covalently bound to CD4 or concanavalin A | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5122468A | Hut-78 cell lines infected with HTLV-III which secrete gp160 | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7217508B1 | Cloned DNA sequence related to genomic RNA of human immunodeficiency virus (HIV-1) | Chemistry; Metallurgy | 4 | Expired |
| US7232654B1 | DNA sequence of the LTR region of human immunodeficiency virus type 1 (HIV-1) | Chemistry; Metallurgy | 4 | Expired |
| US7205102B1 | Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated virus (LAV) and proteins encoded by said LAV genomic RNA | Chemistry; Metallurgy | 4 | Expired |
| US5766844A | Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160. | Chemistry; Metallurgy | 4 | Expired |
| US6328973A | Method of raising neutralizing antibodies against HIV | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6600023B1 | Antibody directed against HIV-1 P25 antigen | Physics | 2 | Expired |
| US5736317A | Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular medium | Chemistry; Metallurgy | 1 | Expired |
| US5876732A | Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160 | Chemistry; Metallurgy | 0 | Expired |
| US6503736B1 | Antibodies to crosslinkers and methods for using the same | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.